Aarkstore.com announces, The Latest market research report is available in its vast collection:
M et P Pharma AG – Product Pipeline Review – 2012
http://www.aarkstore.com/reports/M-et-P-Pharma-AG-Product-Pipeline-Review-2012-217894.html
RSS link of Global Markets Direct
http://www.aarkstore.com/feeds/Global-Markets-Direct.xml
Summary
Global Market Direct’s pharmaceuticals report, “M et P Pharma AG – Product Pipeline Review – 2012” provides data on the M et P Pharma AG’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, M et P Pharma AG’s corporate website, SEC filings, investor presentations and featured press releases, both from M et P Pharma AG and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- M et P Pharma AG – Brief M et P Pharma AG overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of M et P Pharma AG human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of M et P Pharma AG with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
Table of contents:
List of Tables 3
List of Figures 3
M et P Pharma AG Snapshot 4
M et P Pharma AG Overview 4
Key Information 4
Key Facts 4
M et P Pharma AG – Research and Development Overview 5
Key Therapeutic Areas 5
M et P Pharma AG – Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products – Monotherapy 8
M et P Pharma AG – Pipeline Products Glance 9
M et P Pharma AG Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Phase I Products/Combination Treatment Modalities 10
M et P Pharma AG – Early Stage Pipeline Products 11
Pre-Clinical Products/Combination Treatment Modalities 11
M et P Pharma AG – Drug Profiles 12
DopaMat 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
Nasobol 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Noseafix 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
PregnenoMat 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
ProgestoMat 16
Product Description 16
Mechanism of Action 16
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline Review&PubId=&pagenum=1
Infinity Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Intarcia Therapeutics, Inc. – Product Pipeline Review – 2012
InterMed Discovery GmbH – Product Pipeline Review – 2012
Jenrin Discovery, Inc. – Product Pipeline Review – 2012
M et P Pharma AG – Product Pipeline Review – 2012
Fresenius Biotech GmbH – Product Pipeline Review – 2012
Evolva SA – Product Pipeline Review – 2012
Glycotope GmbH – Product Pipeline Review – 2012
Hawthorn Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Helsinn Healthcare S.A. – Product Pipeline Review – 2012
Hygeia Therapeutics, Inc. – Product Pipeline Review – 2012
IkerChem S.L. – Product Pipeline Review – 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1
You can also request for sample page of above mention reports on sample@aarkstore.com
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com
ListFree.org: Embedded data.